H. michael shepard
WebH. Michael Shepard, Ph.D. (64), Vice President, Chief Scientific Officer. Dr. Shepard joined Halozyme in 2009 as Vice President, Discovery Research with extensive experience in the … WebBecause of Dr. H. Michael Shepard’s efforts, women newly diagnosed with invasive breast cancers are always tested for HER2. Herceptin works by attaching itself to the HER2 receptors on the surface of breast cancer cells and blocking them from receiving growth signals. By blocking the signals, Herceptin can slow or stop the growth of the ...
H. michael shepard
Did you know?
WebMar 28, 2024 · The estimated net worth of H. Michael Shepard is at least $456,519 dollars as of 2024-03-21. H. Michael Shepard is the VP, Chief Scientific Officer of Halozyme Therapeutics Inc and owns about 13,198 shares of Halozyme Therapeutics Inc (HALO) stock worth over $456,519. Details can be seen in H. Michael Shepard's Latest Holdings … WebShepard was also scientific program leader for Halozyme’s Phase 3 candidate for pancreatic cancer (Pegylated PH20 hyaluronidase). Shepard currently consults with …
WebDr. Shepard, an innovator in the field of biotechnology and pioneer in cancer research, won the 2024 Lasker-DeBakey Clinical Medical Research Award with colleagues Dr. Dennis J. Slamon and Axel Ullrich due to their work inventing Herceptin—a targeted antibody therapy for breast cancer. WebDr. H. Michael Shepard is a global, leading authority on cancer research and therapeutics. ... Dr. Shepard is a highly-experienced and respected leader with many successful ventures in this field – working at Genentech (sold to Roche – $46.8 B USD), Canji, Inc. (bought by Scheirng-Plough) and Halozyme (now valued at $2.6B USD).
H. Michael Shepard is an American cancer researcher who was awarded the 2024 Lasker Clinical research award, which he shared with Dennis Slamon and Axel Ullrich for their development of Herceptin See more Shepherd holds a bachelor's degree from the University of California, Davis, and a Ph.D. from Indiana University. Dr. Shepard was a Damon Runyon Cancer Research Foundation Fellow at Indiana University. His introduction to … See more Shepard has made seminal contributions to gene therapy of cancer, to tumor suppressor gene targeted small molecule therapeutics, and to drugs which target the tumor extracellular matrix. He continues his work, now expanding successful treatment … See more • Receptor Biologix • Alpert Foundation See more Following Ullrich's characterization of the HER2 protooncogene, Shepard collaborated with Ullrich and Slamon to explore possible links to breast cancer. Slamon discovered, along with other colleagues in the field, that HER2 overexpression in … See more • U.S. Patent 7,138,388 — Methods to treat autoimmune and inflammatory conditions • U.S. Patent 7,105,156 — Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells See more WebOct 16, 2024 · H Michael Shepard, PhD San Juan Unified School District 1.81K subscribers Subscribe 1 Share 80 views 3 years ago H Michael Shepard, PhD - Evening with the …
WebJun 16, 2024 · H. Michael Shepard, Ph.D. is known for leading the research team that discovered the antibody therapy Herceptin (trastuzumab). For this work, in 2024, ...
WebOct 1, 2024 · H. Michael Shepard, Dennis Slamon, and Axel Ullrich are being recognized for their work toward the development of Herceptin, the first targeted-mAb therapy for cancer. Photo of Axel Ullrich courtesy of the Mary and Albert Lasker Foundation. The hunt for cancer-causing genes and therapeutic strategies asda pg tea bagsWebHunter Markus Shepard (born November 7, 1995) is an American professional ice hockey goaltender currently playing with the Hershey Bears in the American Hockey League (AHL) … asda petrol station rainham kentWebSep 10, 2024 · Shepard—an innovator in the field of biotechnology and pioneer in cancer research—earned his Ph.D. in molecular, cellular and developmental biology in 1977 from … asda ph1 5apWebOct 1, 2024 · H. Michael Shepard joined Genentech after completing graduate training with George Malacinski and postdoctoral training with Barry Polisky at Indiana University at … asda pharmacy dunmail parkWebDirector of State Key Laboratory of Bioreactor Engineering, School of Biotechnology, East China University of Science and Technology; Chief Scientist of a “973 Program”; Awardee of the National Science Fund for Distinguished Young Scholars, China Jin Ren Director, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Yingping Zhuang asda pharmacy kendal phone numberasda pharmacy kendal cumbriaWebSep 16, 2024 · About Dr. H. Michael Shepard Dr. Shepard is an American cancer researcher. He received a Ph.D. in Molecular, Cellular and Developmental Biology from the Indiana University and later became a Damon ... asda pharmacy kendal opening times